Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1146 studies found for:    Esophageal Neoplasms
Show Display Options
Rank Status Study
1 Recruiting Irreversible Electroporation(IRE) For Unresectable Esophageal Neoplasms
Condition: Esophageal Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
2 Withdrawn Safety Study on the Transfer of the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma
Condition: Esophageal Neoplasms
Intervention: Genetic: CD40 Gene Transfer
3 Withdrawn Efficacy Study on the Transfer of Adenovirus With the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma
Condition: Esophageal Neoplasms
Interventions: Genetic: AdcuCD40L;   Genetic: Placebo
4 Terminated A Phase III Study of En Bloc Versus Non-En Bloc Esophagectomy in Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Procedure: Esophagectomy
5 Recruiting Docetaxel and S-1 for Advanced Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Drug: DS (docetaxel+S-1)
6 Completed PET-CT Based Radiotherapy in Esophageal Cancer Patients
Condition: Esophageal Neoplasms
Intervention:
7 Recruiting Innovative MRI Techniques to Improve Treatment Stratification of Patients With Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Drug: Ferumoxytol
8 Completed Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer
Condition: Esophageal Neoplasms
Interventions: Drug: Pronase;   Drug: Control
9 Recruiting Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma
Condition: Esophageal Neoplasms
Interventions: Radiation: IMRT simultaneous integrated boost;   Drug: Nimotuzumab;   Drug: Paclitaxel;   Drug: Nedaplatin;   Procedure: Esophagectomy
10 Completed Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Drug: Capecitabine (Xeloda)
11 Recruiting Quality of Life in Neoadjuvant Versus Adjuvant Therapy of Esophageal Cancer Treatment Trial
Condition: Esophageal Neoplasms
Interventions: Other: Preoperative treatment of chemotherapy and radiation;   Other: Postoperative treatment of chemotherapy and radiation
12 Terminated
Has Results
A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer
Condition: Esophageal Neoplasms
Interventions: Drug: Pemetrexed;   Drug: Carboplatin
13 Completed Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial
Condition: Esophageal Neoplasms
Intervention: Drug: irinotecan
14 Active, not recruiting Definitive Chemoradiotherapy and Cetuximab in the Treatment of Locally Advanced Esophageal Cancer
Condition: Esophageal Neoplasm
Intervention: Drug: Cetuximab
15 Completed Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer
Condition: Esophageal Neoplasms
Interventions: Drug: FOLFOX 4;   Drug: 5-FU / Cisplatin
16 Recruiting Comparison of Captivator Tissue Cassettes vs. no Cassettes for Endoscopic Mucosal Resection in Esophageal Carcinoma
Condition: Esophageal Neoplasms
Interventions: Device: Captivator cassette;   Other: Standard of Care
17 Recruiting Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma
Condition: Esophageal Neoplasms
Interventions: Radiation: IMRT simultaneous integrated boost;   Drug: Paclitaxel;   Drug: Nedaplatin;   Procedure: Esophagectomy
18 Recruiting Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma
Conditions: Esophageal Neoplasms;   Esophageal Cancer
Interventions: Radiation: Adjuvant Chemoradiation;   Radiation: Adjuvant Radiation;   Drug: Paclitaxel;   Drug: Cisplatin or Nedaplatin
19 Withdrawn Study for Determination of Feasibility and Toxicity of Pre-Treatment With HPPH (2-1[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a) Photodynamic Therapy Prior to Chemoradiation in Non-Operable Patients With Obstructive Esophageal Cancer
Condition: Esophageal Neoplasm
Intervention: Drug: HPPH 2-1[1-hexyloxyethyl]-2-devinyl Pyropheophorbide-a)
20 Recruiting Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial
Condition: Esophageal Neoplasms
Interventions: Drug: S1;   Drug: S-1;   Drug: irinotecan

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.